The Directorate of Drugs Control (DDC) Punjab has issued an urgent alert and ordered the recall of several medicine batches after they were declared substandard during laboratory testing. According to Beyond Time News, the decision has raised concerns about patient safety and the quality of injectable medicines circulating in the provincial market.
Medicines Declared Substandard
Authorities identified four medical products that failed quality testing conducted by Drug Testing Laboratories Punjab.
The recalled medicines include injectable water solutions and infusion drugs produced by pharmaceutical companies based in different cities, including Islamabad, Lahore, Bannu, and Multan.
Recalled Medicine Batches
- Water for Injection 10 mL
Batch No: B26413 | Expiry: January 2030 - Water for Injection 5 mL
Batch No: 20336 | Expiry: October 2028 - Infusion Promass 100 mL (Paracetamol 1g/100mL)
Batch No: 042 | Expiry: October 2027 - Infusion Brzole 100 mL (Metronidazole 500mg/100mL)
Batch No: 25081 | Expiry: October 2027
According to Beyond Time News, these products failed key safety and quality parameters during testing.
What Tests Did the Medicines Fail?
Officials reported that three products failed the Bacterial Endotoxins Test, which checks for harmful bacterial toxins in injectable medicines.
Meanwhile, one infusion product failed the Visible Particles Test, indicating contamination or quality issues in the solution.
Furthermore, health experts warn that such failures can pose serious risks, especially when the medicines are administered directly into the bloodstream.
Health Safety Concerns Raised
The Punjab health authorities expressed concern over the potential risks linked to substandard injectable medicines.
They noted that:
- Injectable drugs require strict sterility standards
- Even minor contamination can lead to severe complications
- Hospitals and clinics must ensure proper quality checks
According to Beyond Time News, patient safety remains the top priority for regulatory authorities following the recall.
Immediate Recall Orders Issued
The Provincial Quality Control Board has directed all manufacturers and distributors to immediately remove the affected batches from:
- Pharmacies
- Hospitals
- Medical stores
- Distribution networks
Furthermore, companies have been instructed to submit detailed distribution records and conduct internal investigations.
Action Against Manufacturers
Regulators have also required pharmaceutical companies to prepare:
- Root cause analysis reports
- Corrective action plans
- Preventive measures to avoid future quality issues
In addition, the Drug Regulatory Authority of Pakistan (DRAP) has been informed to monitor compliance and further investigation.
Importance of Drug Quality Monitoring
Experts say medicine quality control plays a critical role in ensuring public health safety.
Furthermore, regular testing helps:
- Prevent contaminated drugs from reaching patients
- Maintain trust in healthcare systems
- Strengthen pharmaceutical regulations
According to Beyond Time News, this latest recall highlights the importance of strict monitoring across all stages of drug production and distribution.
Read more:Medicine Prices Surge Across Pakistan, Putting Patients Under Severe Financial Pressure
Conclusion
The recall of substandard medicine batches in Punjab has raised serious concerns about pharmaceutical safety standards. Authorities have taken swift action to remove the affected products from circulation and ensure compliance with quality regulations.
According to Beyond Time News, continued vigilance and stronger enforcement are essential to protect patients and maintain confidence in Pakistan’s healthcare system.
FAQs
1. Why were the medicines recalled?
They were declared substandard after failing laboratory quality tests.
2. Which authority issued the recall?
The Directorate of Drugs Control (DDC) Punjab issued the alert.
3. What types of medicines were affected?
Injectable water solutions and infusion medicines were included in the recall.
4. What risks do substandard injectable medicines pose?
They can cause infections, complications, or serious health risks if administered.
5. What actions have been taken?
Authorities ordered an immediate recall and instructed companies to submit investigation reports.
Hashtags
#PunjabHealth #MedicineRecall #PakistanHealth #DRAP #PublicSafety #HealthcareAlert #PharmaNews #LahoreNews #HealthUpdate #BeyondTimeNews
